東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Radiopharmaceuticals for therapy

Knapp, F. F. (Russ)

Linked to FindBook

Google Book

Amazon

博客來

Radiopharmaceuticals for therapy

Record Type:	Electronic resources : Monograph/item
Title/Author:	Radiopharmaceuticals for therapy/ by F. F. (Russ) Knapp, Ashutosh Dash.
Author:	Knapp, F. F. (Russ)
other author:	Dash, Ashutosh.
Published:	New Delhi :Springer India : : 2016.,
Description:	xxiv, 347 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Radiopharmaceuticals. -
Online resource:	http://dx.doi.org/10.1007/978-81-322-2607-9
ISBN:	9788132226079$q(electronic bk.)

Radiopharmaceuticals for therapy
Knapp, F. F. (Russ)

Radiopharmaceuticals for therapy[electronic resource] /by F. F. (Russ) Knapp, Ashutosh Dash. - New Delhi :Springer India :2016. - xxiv, 347 p. :ill., digital ;24 cm.

This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT) Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.

ISBN: 9788132226079$q(electronic bk.)

Standard No.: 10.1007/978-81-322-2607-9doiSubjects--Topical Terms:

660767
Radiopharmaceuticals.

LC Class. No.: RS431.R34

Dewey Class. No.: 615.842

Radiopharmaceuticals for therapy
LDR:02382nmm a2200301 a 4500 001 2030601
003 DE-He213
005 20160817155819.0
006 m d
007 cr nn 008maaau
008 160908s2016 ii s 0 eng d
020 $a 9788132226079$q(electronic bk.)
020 $a 9788132226062$q(paper)
024 7 $a 10.1007/978-81-322-2607-9 $2 doi
035 $a 978-81-322-2607-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RS431.R34
072 7 $a MMN $2 bicssc
072 7 $a MED080000 $2 bisacsh
082 0 4 $a 615.842 $2 23
090 $a RS431.R34 $b K67 2016
100 1 $a Knapp, F. F. (Russ) $3 2182525
245 1 0 $a Radiopharmaceuticals for therapy $h [electronic resource] / $c by F. F. (Russ) Knapp, Ashutosh Dash.
260 $a New Delhi : $b Springer India : $b Imprint: Springer, $c 2016.
300 $a xxiv, 347 p. : $b ill., digital ; $c 24 cm.
520 $a This book provides detailed information on therapeutic radiopharmaceuticals and discusses emerging technologies which have potential for broad clinical implementation. Recent advances in molecular biology, radiopharmaceutical chemistry and radioisotope production have stimulated a new era for the use of radiopharmaceuticals for targeted radionuclide therapy (TRT) Emerging clinical trials include use of peptides and monoclonal antibodies radiolabeled with therapeutic radionuclides for cancer therapy. In addition, small molecules are used for the treatment of chronic diseases such as metastatic bone pain palliation and radiation synovectomy of inflammatory joints. In the interventional arena, therapy of primary and metastatic liver cancer and arterial restenosis following angioplasty of both the coronary and peripheral arteries are being explored. Reactor and accelerator production of therapeutic radioisotopes is also integrated into these discussions. The development and use of radiopharmaceutical targeting characteristics required for treatment of specific disease processes and how these are implemented for radiopharmaceutical design strategies are also described. Radiopharmaceuticals for Therapy will benefit audiences in nuclear medicine and radionuclide therapy and will thus prove an invaluable source of up-to-date information for students, radiopharmaceutical scientists and professionals working in the radiopharmacy and nuclear medicine specialties.
650 0 $a Radiopharmaceuticals. $3 660767
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Nuclear Medicine. $3 823642
650 2 4 $a Pharmacotherapy. $3 1978501
650 2 4 $a Oncology. $3 751006
650 2 4 $a Endocrinology. $3 610914
700 1 $a Dash, Ashutosh. $3 2182526
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-81-322-2607-9
950 $a Medicine (Springer-11650)